These genetic findings raise the possibility that variants p.Gln1670* or p.Glu1984* identified in two older patients can disrupt processes such as histone variant H3.3-ATRX or MECP2-ATRX interaction leading to reduced or missing expressing of the neuroblastoma ATRX protein. The gene discussed is MECP2; the disease is neuroblastoma.